Robert Banerjea focuses his practice on mergers and acquisitions, private equity, securities transactions and general corporate matters. He has advised public and private clients on a broad range of domestic and cross-border matters, including acquisitions, divestitures, joint ventures, restructurings, initial public offerings, financings, corporate governance, shareholder activism and takeover preparedness. He also represents investment banks as financial advisors in M&A transactions. In addition, Mr. Banerjea has represented pro bono clients in death penalty, clemency and asylum cases. Mr. Banerjea has authored and co-authored numerous publications on M&A and corporate law issues, including a treatise on derivative actions. Prior to joining Skadden, he worked as an investment banker at a bulge bracket investment bank and, before that, as a lawyer in the German offices of a Magic Circle law firm.

Examples of Mr. Banerjea’s representations include:

  • A. Schulman, Inc. in its $2.25 billion acquisition by LyondellBasell Industries N.V.;
  • Keurig Green Mountain, Inc. in its merger with Dr Pepper Snapple Group, Inc.;
  • BioCryst Pharmaceuticals, Inc. in its proposed merger with Idera Pharmaceuticals, Inc.;
  • Kelso & Company in its acquisition of a majority stake in Foundation Consumer Healthcare, a pharmaceutical company owned by Juggernaut Capital Partners, and in Foundation’s concurrent acquisition of Plan B One-Step and other value brands of emergency contraceptives from Teva Pharmaceuticals Industries, Ltd. for $675 million in cash;
  • Citigroup Inc. in the sale of its fixed income analytics platform and related index businesses to London Stock Exchange Group PLC for $685 million;
  • Sentinel Data Centers in its $490 million sale of a data center portfolio to Cyrus One Inc., a global data center REIT;
  • Keurig Green Mountain, Inc. in a joint venture with Anheuser-Busch InBev focused on the research and development of an in-home alcohol drink system;
  • Grupo Ferrer Internacional, S.A. in the acquisition of Alexza Pharmaceuticals, Inc.;
  • Deutsche Bank affiliate German American Capital Corporation, as a significant shareholder, in the $531 million initial public offering of casino operator Red Rock Resorts, Inc. and the related $460 million acquisition by Red Rock of its provider of management services, Fertitta Entertainment LLC;
  • insurance brokerage NFP Corp. in the acquisition of BWD Group;
  • Deluxe Entertainment Services Group Inc., a subsidiary of MacAndrews & Forbes Incorporated, in its digital cinema joint venture with Technicolor S.A.;
  • Wasserstein & Co. in its sale of High Pressure Equipment Company LLC to Graco Inc. for $160 million; and
  • Credit Suisse Group AG in the sale of its Customized Fund Investment Group to Grosvenor Capital Management, L.P.



  • LL.M., New York University School of Law, 2002
  • Dr. jur., University of Bonn, 2000
  • Second State Exam, State of North Rhine-Westphalia, 2001
  • First State Exam, University of Cologne, Law Faculty, 1997


  • New York

Robert Banerjea

Associate, Mergers and Acquisitions; Financial Institutions